Literature DB >> 21274374

Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy.

Anna Zub-Pokrowiecka1, Kazimierz Rembiasz, Peter C Konturek, Andrzej Budzyński, Stanisław J Konturek, Marek Winiarski, Władysław Bielański.   

Abstract

AIM: To investigate plasma ghrelin, gastrin and growth hormone secretagogue receptor (GHS-R) expression in advanced gastric cancer (GC) before and after resection.
METHODS: Seventy subjects in whom endoscopy of the upper gastrointestinal tract was performed in the Department of General Surgery at Cracow University during the past decade: (1) 25 patients with GC associated with Helicobacter pylori (H. pylori) infection; (2) 10 patients with GC 4-5 years after (total or subtotal) gastrectomy; (3) 25 healthy H. pylori-negative controls, matched by age and BMI to the above two groups; and (4) 10 GC patients 4-5 years after total gastrectomy. Ghrelin and gastrin plasma concentrations were measured by specific radioimmunoassay under fasting conditions and postprandially at 60 and 90 min after ingestion of a mixed meal. GHS-R expression was examined in biopsy samples from intact healthy mucosa and GC tissue using semi-quantitative reverse transcription-polymerase chain reaction.
RESULTS: In healthy controls, fasting plasma ghrelin levels were significantly elevated and declined markedly at 60 and 90 min after a mixed meal. The concomitant enhanced ghrelin, GHS-R and gastrin expression in GC tissue over that recorded in intact mucosa, and the marked rise in plasma gastrin in these subjects under fasting conditions indicate the role of these hormonal factors in GC formation. Fasting plasma levels and postprandial response of ghrelin and gastrin appear to be inversely correlated in healthy subjects. Feeding in the controls resulted in a significant fall in plasma ghrelin with a subsequent rise in plasma gastrin, but in H. pylori-positive GC patients submitted to total or distal gastrectomy, feeding failed to affect significantly the fall in plasma ghrelin that was recorded in these patients before surgery. Fasting ghrelin concentrations were significantly lower in patients 4-5 years after total gastrectomy compared to those in healthy controls and to these in GC patients before surgery.
CONCLUSION: Elevated plasma gastrin and suppression of fasting ghrelin in patients with GC suggest the existence of a close relationship between these two hormones in gastric carcinogenesis.

Entities:  

Keywords:  Gastric cancer; Gastric resection; Gastrin; Ghrelin

Mesh:

Substances:

Year:  2011        PMID: 21274374      PMCID: PMC3027011          DOI: 10.3748/wjg.v17.i4.449

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing.

Authors:  Hiroshi Hosoda; Masayasu Kojima; Tsunekazu Mizushima; Shigeomi Shimizu; Kenji Kangawa
Journal:  J Biol Chem       Date:  2002-10-31       Impact factor: 5.157

2.  Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy.

Authors:  Ko Takachi; Yuichiro Doki; Osamu Ishikawa; Isao Miyashiro; Yo Sasaki; Hiroaki Ohigashi; Kohei Murata; Hiromu Nakajima; Hiroshi Hosoda; Kenji Kangawa; Fujiko Sasakuma; Shingi Imaoka
Journal:  J Surg Res       Date:  2005-09-22       Impact factor: 2.192

3.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

Review 4.  Cancerogenesis in Helicobacter pylori infected stomach--role of growth factors, apoptosis and cyclooxygenases.

Authors:  P C Konturek; S J Konturek; P Pierzchalski; W Bielański; A Duda; K Marlicz; T Starzyńska; E G Hahn
Journal:  Med Sci Monit       Date:  2001 Sep-Oct

5.  Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer.

Authors:  Tae Yong Jeon; Sangyeoup Lee; Hyoung Hoi Kim; Yun Jin Kim; Han Chul Son; Dong Heon Kim; Mun Sup Sim
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

6.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.

Authors:  Y Date; M Kojima; H Hosoda; A Sawaguchi; M S Mondal; T Suganuma; S Matsukura; K Kangawa; M Nakazato
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

Authors:  H Ariyasu; K Takaya; T Tagami; Y Ogawa; K Hosoda; T Akamizu; M Suda; T Koh; K Natsui; S Toyooka; G Shirakami; T Usui; A Shimatsu; K Doi; H Hosoda; M Kojima; K Kangawa; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

Review 9.  Brain-gut axis and its role in the control of food intake.

Authors:  S J Konturek; J W Konturek; T Pawlik; T Brzozowski
Journal:  J Physiol Pharmacol       Date:  2004-03       Impact factor: 3.011

Review 10.  Ghrelin: central and peripheral effects of a novel peptydil hormone.

Authors:  Marco De Ambrogi; Sara Volpe; Carlo Tamanini
Journal:  Med Sci Monit       Date:  2003-09
View more
  6 in total

1.  Ghrelin Affects Gastric Cancer Progression by Activating AMPK Signaling Pathway.

Authors:  Xiao-Lin Hu; Yong-Jun Zhu; Chang-Hua Hu; Li You; Juan Wu; Xiao-Yan He; Wen-Jie Huang; Zong-Hui Wu
Journal:  Biochem Genet       Date:  2021-01-13       Impact factor: 1.890

Review 2.  Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy.

Authors:  Shuji Takiguchi; Akihiro Takata; Kohei Murakami; Yasuhiro Miyazaki; Yoshitomo Yanagimoto; Yukinori Kurokawa; Tsuyoshi Takahashi; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2013-09-20       Impact factor: 7.370

3.  Postoperative Body Mass Index Changes in Gastric Cancer Patients according to Reconstruction Type: Effectiveness of Long Jejunal Bypass on Weight Loss in Obese Patients after Distal Gastrectomy.

Authors:  Ji Won Kim; So Young Jung; Ji Woong Cho; Byung Chun Kim; Kyung Suk Chung; Dae Hyun Yang
Journal:  Indian J Surg       Date:  2012-07-08       Impact factor: 0.656

Review 4.  Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review.

Authors:  Sakine Sever; Donna L White; José M Garcia
Journal:  Endocr Relat Cancer       Date:  2016-09       Impact factor: 5.678

Review 5.  Attribution of Ghrelin to Cancer; Attempts to Unravel an Apparent Controversy.

Authors:  Saeed Soleyman-Jahi; Fatemeh Sadeghi; Amin Pastaki Khoshbin; Leila Khani; Venus Roosta; Kazem Zendehdel
Journal:  Front Oncol       Date:  2019-10-16       Impact factor: 6.244

6.  Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis.

Authors:  Alireza Sadjadi; Abbas Yazdanbod; Yeong Yeh Lee; Majid Boreiri; Fatemeh Samadi; Behrooz Z Alizadeh; Farhad Islami; Valerie Fyfe; Masoud Babaei; Mohammad J Namazi; James J Going; Masoud Sotoudeh; Geertruida H de Bock; Reza Malekzadeh; Mohammad H Derakhshan
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.